Medicine

Integrating liver endpoints in clinical trials of heart and renal disease

.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for addition of people with MASLD and also dimension of liver results in cardio-- kidney-- metabolic tests, when data suggest mechanistically tenable perks as well as medical safety and security-- and outlines points to consider for test style as well as regulative commendation.